Segall Bryant & Hamill’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-7,450
Closed -$957K 564
2023
Q2
$957K Buy
7,450
+270
+4% +$32.7K 0.01% 489
2023
Q1
$834K Sell
7,180
-300
-4% -$33.6K 0.01% 510
2022
Q4
$847K Sell
7,480
-300
-4% -$32.9K 0.01% 512
2022
Q3
$627K Sell
7,780
-840
-10% -$71.1K 0.01% 544
2022
Q2
$643K Sell
8,620
-160
-2% -$14.6K 0.01% 548
2022
Q1
$1.12M Hold
8,780
0.01% 502
2021
Q4
$1.18M Hold
8,780
0.01% 443
2021
Q3
$1.2M Hold
8,780
0.01% 507
2021
Q2
$936K Sell
8,780
-99,328
-92% -$9.54M 0.01% 529
2021
Q1
$9.71M Buy
108,108
+99,328
+1,131% +$9.32M 0.1% 223
2020
Q4
$811K Buy
8,780
+640
+8% +$57.1K 0.01% 500
2020
Q3
$839K Buy
8,140
+940
+13% +$98.2K 0.01% 478
2020
Q2
$730K Hold
7,200
0.01% 507
2020
Q1
$485K Hold
7,200
0.01% 598
2019
Q4
$394K Sell
7,200
-1,880
-21% -$89.2K 0.01% 690
2019
Q3
$339K Hold
9,080
0.01% 713
2019
Q2
$340K Buy
+9,080
New +$285K 0.01% 722

Other funds holding DXCM